In This Section

Newsroom

  • Bashir

    Anatomic Compression of Iliac Vein Major Factor in Pulmonary Vascular Disease, Temple Researchers Report

    In many cases, the clots that cause CTEPH come from veins in the lower half of the body, usually due to deep vein thrombosis (DVT). A risk factor for DVT is compression of the iliac vein in the pelvis, which can be caused by an anatomical variant known as May-Thurner anatomy (MTA). While MTA is generally thought to be rare, a new study by researchers at the Lewis Katz School of Medicine shows that the anomaly is very common in patients with CTEPH – in a sample of 148 patients referred to Temple’s CTEPH program since 2016, nearly 30 percent were found to have MTA.

  • Drs. Khalili and Burdo - HIV Research

    Temple Researchers Take Another Step Toward Curing HIV

    In 2014, Temple University researchers proved they could use state-of-the-art molecular scissors to cut out dormant HIV hiding in human cells in lab dishes. Now, seven years later — the blink of an eye in basic research — the approach has received Food and Drug Administration approval for testing in humans, buoying hopes for curing, not just suppressing, the insidious virus that causes AIDS. Although the world is focused on the COVID-19 pandemic, HIV/AIDS continues to rage in many poor countries 40 years after it was identified.

  • Drs. Khalili and Burdo - HIV Research

    Groundbreaking Research at Temple Paves Way for First Trial of CRISPR-Based HIV Therapy in Human Patients

    For the last seven years, researchers at the Lewis Katz School of Medicine have been developing and refining CRISPR-based gene-editing technology for the treatment of human immunodeficiency virus type 1 (HIV) infection. Out of that effort has emerged a potentially revolutionizing therapy known as EBT-101, which thanks to recent acceptance as an Investigational New Drug (IND) by the U.S. Food and Drug Administration, could become the first functional cure for chronic HIV infection. The new IND approval for EBT-101 opens the way to the first Phase 1/2 clinical trials of a CRISPR-based therapy for HIV infection. The clinical trials will be initiated and managed by Excision BioTherapeutics, Inc., which has been a major collaborator with Temple on the development of CRISPR-based systems for the treatment of HIV.

  • Dr. Sammon -CBS3

    Dr. Maura Sammon Joins CBS3 to Discuss Helping Care for Afghan Evacuees Arriving at Philadelphia International Airport

    Maura Sammon, MD, Associate Professor of Clinical Emergency Medicine, spoke with CBS3 about helping care for Afghan evacuees who have arrived at Philadelphia International Airport. The evacuees undergo medical screenings, COVID testing and urgent care treatment if necessary.

  • Dawn Marks Research Day

    Graduate Student Research Showcased During Dawn Marks Research Day

    After moving online in 2020, the annual Dawn Marks Research Day, the popular student research showcase at the Lewis Katz School of Medicine, returned in-person on August 27 for its 20th year.  

  • Joice - Student Spotlight

    Student Spotlight: Joice Kanefsky, Biomedical Sciences Program

    Joice Kanefsky, 28, is beginning her fourth year as a PhD student in the Biomedical Sciences Graduate Program at Temple University’s Lewis Katz School of Medicine. She is a native of the state of Minas Gerais in Brazil and a graduate of Universidade Federal de Minas Gerais. As president of the Graduate Student Association, she organized the Dawn Marks Research Day that was held on Friday, August 27, at Temple’s Medical Education and Research Building. Thirty-five MS, PhD, and MD/PhD students displayed posters or made oral presentations describing their research findings. Everyone from the medical school was invited to attend.

  • MERB

    OHEDI Launches an Awards Program for Those Who Go ‘Above and Beyond’

    Nominations are being accepted for a new Health Equity Leadership & Social Justice Award launched by the Office of Diversity, Inclusion and Health Equity (OHEDI). The award is designed to celebrate national heritage months by highlighting colleagues in healthcare whose work exemplifies excellence on behalf of people and groups who are underrepresented in medicine and/or disenfranchised in society.

  • Beata Kosmider

    Faculty Spotlight: Beata Kosmider, PhD

    Beata Kosmider, PhD, Associate Professor of Microbiology, Immunology, and Inflammation at the Lewis Katz School of Medicine, is researching ways to stimulate certain cells in the lungs to regenerate so they can repair injury and slow the progression of emphysema. 

Pages